Patrick Johnston

966 total citations
21 papers, 704 citations indexed

About

Patrick Johnston is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrick Johnston has authored 21 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrick Johnston's work include Colorectal Cancer Treatments and Studies (8 papers), Cancer, Lipids, and Metabolism (3 papers) and Biochemical and Molecular Research (3 papers). Patrick Johnston is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Cancer, Lipids, and Metabolism (3 papers) and Biochemical and Molecular Research (3 papers). Patrick Johnston collaborates with scholars based in United Kingdom, United States and Germany. Patrick Johnston's co-authors include Daniel B. Longley, Eric Van Cutsem, Anthi Karaı̈skou, Leeona Galligan, Sandra Van Schaeybroeck, K A Behan, Daniel J. Sargent, Michelle R. Mahoney, Maria Tria Tirona and Lester E. Wold and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Patrick Johnston

21 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Johnston United Kingdom	12	460	206	159	142	92	21	704
B D Evans New Zealand	11	362 0.8×	217 1.1×	113 0.7×	115 0.8×	107 1.2×	24	728
Maki Tanioka Japan	17	335 0.7×	261 1.3×	89 0.6×	111 0.8×	166 1.8×	76	841
Merry Tetef United States	14	269 0.6×	147 0.7×	78 0.5×	119 0.8×	118 1.3×	29	581
Fadi Farhat Lebanon	17	196 0.4×	188 0.9×	50 0.3×	234 1.6×	82 0.9×	55	684
Cristina Pérez-Ramírez Spain	14	211 0.5×	309 1.5×	156 1.0×	161 1.1×	177 1.9×	50	762
Maja J. De Jonge Netherlands	16	449 1.0×	471 2.3×	91 0.6×	298 2.1×	114 1.2×	43	849
Davide Lombardi Italy	17	609 1.3×	210 1.0×	61 0.4×	308 2.2×	211 2.3×	57	1.0k
J. Carmichael United Kingdom	16	635 1.4×	299 1.5×	128 0.8×	134 0.9×	178 1.9×	24	987
Alejandro Yovine France	11	422 0.9×	126 0.6×	104 0.7×	428 3.0×	145 1.6×	24	732
Daphne Voorn Netherlands	16	539 1.2×	389 1.9×	90 0.6×	213 1.5×	136 1.5×	21	911

Countries citing papers authored by Patrick Johnston

Since Specialization

Citations

This map shows the geographic impact of Patrick Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Johnston more than expected).

Fields of papers citing papers by Patrick Johnston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Johnston. The network helps show where Patrick Johnston may publish in the future.

Co-authorship network of co-authors of Patrick Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Johnston. A scholar is included among the top collaborators of Patrick Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Johnston. Patrick Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Danenberg, Peter V., Bengt Gustavsson, Patrick Johnston, et al.. (2016). Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action. Critical Reviews in Oncology/Hematology. 106. 118–131. 39 indexed citations

Selby, Peter J., Mark Lawler, Ian Banks, Patrick Johnston, & Paul Nurse. (2016). The EU: what's best for UK cancer research and patients?. The Lancet Oncology. 17(5). 556–557. 4 indexed citations

Bradley, Conor A., Philip D. Dunne, Darragh G. McArt, et al.. (2015). Abstract 4018: The role of c-MET/HGF signaling as a critical mediator of an invasive and resistant phenotype in colorectal cancer. Cancer Research. 75(15_Supplement). 4018–4018. 1 indexed citations

Gourley, Charlie, Timothy Perren, James Paul, et al.. (2014). Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab.. Journal of Clinical Oncology. 32(15_suppl). 5502–5502. 76 indexed citations

Dunne, Philip D., Darragh G. McArt, Jaine K. Blayney, et al.. (2014). EpHA2 is an essential driver of invasion and a novel target in KRAS mutant colorectal cancer. Research Portal (Queen's University Belfast). 1 indexed citations

Turkington, Richard, Laura A. Hill, Damian McManus, et al.. (2014). Association of a DNA damage response deficiency (DDRD) assay and prognosis in early-stage esophageal adenocarcinoma.. Journal of Clinical Oncology. 32(15_suppl). 4015–4015. 2 indexed citations

McMullin, M. F., Ken Mills, Robert K. Hills, et al.. (2009). THE PROGNOSTIC ROLE OF C-FLIP IN AML. 94. 108–108. 1 indexed citations

El‐Tanani, Mohamed, et al.. (2008). The Role of LEF/TCF Factors in Neoplastic Transformation. Current Molecular Medicine. 8(1). 38–50. 32 indexed citations

Wilson, Catherine, Timothy R. Wilson, Patrick Johnston, Daniel B. Longley, & David Waugh. (2007). Interleukin-8/CXCR2 signaling plays an important role in conferring resistance of prostate cancer cells to chemotherapy. Molecular Cancer Therapeutics. 6. 2 indexed citations

10.

McLornan, Donal P., Mary Frances McMullin, Patrick Johnston, & Daniel B. Longley. (2007). Molecular mechanisms of drug resistance in acute myeloid leukaemia. Expert Opinion on Drug Metabolism & Toxicology. 3(3). 363–377. 19 indexed citations

11.

Seaton, Angela, et al.. (2006). CXCR2/NF-kappaB/Bcl-2-survivin signalling pathway promotes resistance to oxaliplatin in metastatic prostate cancer cells. Cancer Research. 66. 880–880. 2 indexed citations

12.

Johnston, Patrick, et al.. (2006). Predicting the outcome of chemotherapy for colorectal cancer. Current Opinion in Pharmacology. 6(4). 332–336. 22 indexed citations

13.

Blohmer, Jens‐Uwe, Jürgen Dunst, Louis B. Harrison, et al.. (2005). Cancer-Related Anemia: Biological Findings, Clinical Implications and Impact on Quality of Life. Oncology. 68(Suppl. 1). 12–21. 56 indexed citations

14.

Schaeybroeck, Sandra Van, Anthi Karaı̈skou, Daniel B. Longley, et al.. (2005). Epidermal Growth Factor Receptor Activity Determines Response of Colorectal Cancer Cells to Gefitinib Alone and in Combination with Chemotherapy. Clinical Cancer Research. 11(20). 7480–7489. 89 indexed citations

15.

Mullan, Paul B., Heather N. Andrews, Jennifer E. Quinn, et al.. (2003). BRCA1 regulates the interferon gamma-mediated apoptotic response.. Clinical Cancer Research. 9. 2 indexed citations

16.

Longley, Daniel B., et al.. (2003). The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells. Seminars in Oncology. 30(3). 3–9. 39 indexed citations

17.

Poole, Christopher, J. Gardiner, Chris Twelves, et al.. (2002). Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients. Cancer Chemotherapy and Pharmacology. 49(3). 225–234. 100 indexed citations

18.

Cutsem, Eric Van, M. Dicato, J. Wils, et al.. (2002). Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). European Journal of Cancer. 38(11). 1429–1436. 45 indexed citations

19.

Groziak, Michael P., Maria V. Sergeeva, Malgorzata Beryt, et al.. (2001). Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase11Abbreviations: BVdU, (E)-5-(2-bromovinyl)-2′-deoxyuridine; BVdUMP, (E)-5-(2-bromovinyl)-2′-deoxyuridine 5′-monophosphate; NB1011, (E)-5-(2-bromovinyl)-2′-deoxy-5′-uridyl phenyl l-methoxyalaninylphosphoramidate; COSY, correlated spectroscopy; DCI, direct current ionization; DMF, N,N-dimethylformamide; dUMP, 2′-deoxyuridine 5′-monophosphate; ECTA, enzyme-catalyzed therapeutic agent; 5-FU, 5-fluorouracil; 5-FdUMP, 5-fluoro-2′-deoxyuridine 5′-monophosphate; RFU, relative fluorescence units; THF, N5,N10-methylene tetrahydrofolate; TBDMS, tert-butyldimethylsilyl; and TS, thymidylate synthase (EC 2.1.1.45).. Biochemical Pharmacology. 61(2). 179–189. 29 indexed citations

20.

Johnston, Patrick, et al.. (1989). Clinical Correlation of Tumor Endocrine Markers in Lung Cancer. Cancer treatment and research. 45. 137–149. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact